Optimization of Lipid Nanoformulations for Effective mRNA Delivery

References

• Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol. 2011;11(12):865–872. doi:10.1038/nri3085
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet. 2008;9(10):776–788. doi:10.1038/nrg2432
   PubMed Web of Science ®Google Scholar
• Fletcher S, Hamilton AD. Targeting protein-protein interactions by rational design: mimicry of protein surfaces. J Royal Soc Interface. 2006;3(7):215–233.
   PubMed Web of Science ®Google Scholar
• Kofler RM, Aberle JH, Aberle SW, Allison SL, Heinz FX, Mandl CW. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc Natl Acad Sci USA. 2004;101(7):1951–1956. doi:10.1073/pnas.0307145101
   PubMed Web of Science ®Google Scholar
• Smerdou C, Liljeström P. Non-viral amplification systems for gene transfer: vectors based on alphaviruses. Curr Opin Mol Ther. 1999;1(2):244–251.
   PubMed Web of Science ®Google Scholar
• Van Tendeloo VF, Ponsaerts P, Berneman ZN. mRNA-based gene transfer as a tool for gene and cell therapy. Curr Opin Mol Ther. 2007;9(5):423–431.
   PubMedGoogle Scholar
• Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17–58. doi:10.1007/3-540-32636-7_2
   PubMed Web of Science ®Google Scholar
• Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618–630. doi:10.1016/j.stem.2010.08.012
   PubMed Web of Science ®Google Scholar
• Van Driessche A, Ponsaerts P, Van Bockstaele DR, Van Tendeloo VF, Berneman ZN. Messenger RNA electroporation: an efficient tool in immunotherapy and stem cell research. Folia Histochemica Et Cytobiologica. 2005;43(4):213–216.
   PubMed Web of Science ®Google Scholar
• Ponsaerts P, Van Tendeloo VF, Berneman ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol. 2003;134(3):378–384. doi:10.1046/j.1365-2249.2003.02286.x
   PubMed Web of Science ®Google Scholar
• Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics–developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–780. doi:10.1038/nrd4278
   PubMed Web of Science ®Google Scholar
• Probst J, Weide B, Scheel B, et al. Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther. 2007;14(15):1175–1180. doi:10.1038/sj.gt.3302964
   PubMed Web of Science ®Google Scholar
• Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol. 2000;30(1):1–7.
   PubMed Web of Science ®Google Scholar
• Kormann MS, Hasenpusch G, Aneja MK, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol. 2011;29(2):154–157. doi:10.1038/nbt.1733
   PubMed Web of Science ®Google Scholar
• Dewitte H, Van Lint S, Heirman C, et al. The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy. J Control Release. 2014;194:28–36. doi:10.1016/j.jconrel.2014.08.011
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Takemoto T. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Sci Rep. 2015;5:11315. doi:10.1038/srep11315
   PubMed Web of Science ®Google Scholar
• Fotin-Mleczek M, Duchardt KM, Lorenz C, et al. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother. 2011;34(1):1–15. doi:10.1097/CJI.0b013e3181f7dbe8
   PubMed Web of Science ®Google Scholar
• Hess PR, Boczkowski D, Nair SK, Snyder D, Gilboa E. Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Immunol Immunother. 2006;55(6):672–683. doi:10.1007/s00262-005-0064-z
   PubMed Web of Science ®Google Scholar
• Ying B, Campbell RB. Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature. Biochem Biophys Res Commun. 2014;446(2):441–447. doi:10.1016/j.bbrc.2014.02.120
   PubMed Web of Science ®Google Scholar
• Scheel B, Teufel R, Probst J, et al. Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA. Eur J Immunol. 2005;35(5):1557–1566. doi:10.1002/eji.200425656
   PubMed Web of Science ®Google Scholar
• Brito LA, Chan M, Shaw CA, et al. A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Mol Ther. 2014;22(12):2118–2129. doi:10.1038/mt.2014.133
   PubMed Web of Science ®Google Scholar
• Démoulins T, Milona P, Englezou PC, et al. Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines. Nanomed Nanotechnol Biol Med. 2016;12(3):711–722. doi:10.1016/j.nano.2015.11.001
   PubMed Web of Science ®Google Scholar
• Goswami R, Chatzikleanthous D, Lou G, et al. Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines. ACS Infect Dis. 2019;5(9):1546–1558. doi:10.1021/acsinfecdis.9b00084
   PubMed Web of Science ®Google Scholar
• Jayaraman M, Ansell SM, Mui BL, et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angewandte Chemie. 2012;51(34):8529–8533. doi:10.1002/anie.201203263
   Google Scholar
• Vu MN, Kelly HG, Tan HX, et al. Hemagglutinin functionalized liposomal vaccines enhance germinal center and follicular helper T cell immunity. Adv Healthc Mater. 2021;10(10):e2002142. doi:10.1002/adhm.202002142
   PubMed Web of Science ®Google Scholar
• Richner JM, Himansu S, Dowd KA, et al. Modified mRNA vaccines protect against zika virus infection. Cell. 2017;168(6):1114–1125.e1110. doi:10.1016/j.cell.2017.02.017
   PubMed Web of Science ®Google Scholar
• Kauffman KJ, Dorkin JR, Yang JH, et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 2015;15(11):7300–7306. doi:10.1021/acs.nanolett.5b02497
   PubMed Web of Science ®Google Scholar
• Henriksen-Lacey M, Christensen D, Bramwell VW, et al. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N’,N’-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses. Mol Pharm. 2011;8(1):153–161. doi:10.1021/mp100208f
   PubMed Web of Science ®Google Scholar
• McNeil SE, Vangala A, Bramwell VW, Hanson PJ, Perrie Y. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies. Curr Drug Deliv. 2010;7(2):175–187. doi:10.2174/156720110791011774
   PubMedGoogle Scholar
• Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91–100. doi:10.1016/j.jconrel.2019.04.015
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhang C, Walker PG, Dong Y. Formulation and delivery technologies for mRNA vaccines. Curr Top Microbiol Immunol. 2020. doi:10.1007/82_2020_217
   Google Scholar
• Simberg D, Weisman S, Talmon Y, Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst. 2004;21(4):257–317. doi:10.1615/CritRevTherDrugCarrierSyst.v21.i4.10
   PubMed Web of Science ®Google Scholar
• Kranz LM, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534(7607):396–401. doi:10.1038/nature18300
   PubMed Web of Science ®Google Scholar
• Filipczak N, Pan J, Yalamarty SSK, Torchilin VP. Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020;156:4–22. doi:10.1016/j.addr.2020.06.022
   PubMed Web of Science ®Google Scholar
• Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer. 2021;20(1):41. doi:10.1186/s12943-021-01335-5
   PubMed Web of Science ®Google Scholar
• Thevenot J, Troutier AL, David L, Delair T, Ladavière C. Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids. Biomacromolecules. 2007;8(11):3651–3660. doi:10.1021/bm700753q
   PubMed Web of Science ®Google Scholar
• Ringer S. Regarding the action of hydrate of soda, hydrate of ammonia, and hydrate of potash on the ventricle of the frog’s heart. J Physiol. 1882;3(3–4):195–202.196. doi:10.1113/jphysiol.1882.sp000095
   PubMedGoogle Scholar
• Lee JA. Sydney Ringer (1834–1910) and Alexis Hartmann (1898–1964). Anaesthesia. 1981;36(12):1115–1121. doi:10.1111/j.1365-2044.1981.tb08698.x
   PubMed Web of Science ®Google Scholar
• Wang L, Wang X, Li X. Isotonic sodium bicarbonate-triggered emodin release from borate stabilized emodin nanoparticles-loaded polymeric microgel films. Int J Pharm. 2014;469(1):80–87. doi:10.1016/j.ijpharm.2014.04.046
   PubMed Web of Science ®Google Scholar
• Misra A, Jinturkar K, Patel D, Lalani J, Chougule M. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin Drug Deliv. 2009;6(1):71–89. doi:10.1517/17425240802652309
   PubMed Web of Science ®Google Scholar
• Jensen GM. The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome(®)). J Liposome Res. 2017;27(3):173–179. doi:10.1080/08982104.2017.1380664
   PubMed Web of Science ®Google Scholar
• Chen C, Han D, Cai C, Tang X. An overview of liposome lyophilization and its future potential. J Control Release. 2010;142(3):299–311. doi:10.1016/j.jconrel.2009.10.024
   PubMed Web of Science ®Google Scholar
• Wroblewska L, Kitada T, Endo K, et al. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery. Nat Biotechnol. 2015;33(8):839–841. doi:10.1038/nbt.3301
   PubMed Web of Science ®Google Scholar
• Muralidharan B, Bakthavachalu B, Pathak A, Seshadri V. A minimal element in 5ʹUTR of insulin mRNA mediates its translational regulation by glucose. FEBS Lett. 2007;581(21):4103–4108. doi:10.1016/j.febslet.2007.07.050
   PubMed Web of Science ®Google Scholar
• Chen X, Wang X, Wang Y, et al. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J Control Release. 2010;145(1):17–25. doi:10.1016/j.jconrel.2010.03.007
   PubMed Web of Science ®Google Scholar
• Che J, Okeke CI, Hu ZB, Xu J. DSPE-PEG: a distinctive component in drug delivery system. Curr Pharm Des. 2015;21(12):1598–1605. doi:10.2174/1381612821666150115144003
   PubMed Web of Science ®Google Scholar
• Guerrero-Cázares H, Tzeng SY, Young NP, Abutaleb AO, Quiñones-Hinojosa A, Green JJ. Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano. 2014;8(5):5141–5153. doi:10.1021/nn501197v
   PubMed Web of Science ®Google Scholar
• Tavernier G, Andries O, Demeester J, Sanders NN, De Smedt SC, Rejman J. mRNA as gene therapeutic: how to control protein expression. J Control Release. 2011;150(3):238–247. doi:10.1016/j.jconrel.2010.10.020
   PubMed Web of Science ®Google Scholar
• Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303(5663):1526–1529. doi:10.1126/science.1093620
   PubMed Web of Science ®Google Scholar
• Zukancic D, Suys EJA, Pilkington EH, Algarni A, Al-Wassiti H, Truong NP. The importance of poly(ethylene glycol) and lipid structure in targeted gene delivery to lymph nodes by lipid nanoparticles. Pharmaceutics. 2020;12(11):1068. doi:10.3390/pharmaceutics12111068
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Ma Y, Wang C, et al. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution. J Control Release. 2012;159(1):135–142. doi:10.1016/j.jconrel.2011.12.017
   PubMed Web of Science ®Google Scholar
• Carralot JP, Probst J, Hoerr I, et al. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. CMLS. 2004;61(18):2418–2424. doi:10.1007/s00018-004-4255-0
   PubMed Web of Science ®Google Scholar
• Alberer M, Gnad-Vogt U, Hong HS, et al. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human Phase 1 clinical trial. Lancet. 2017;390(10101):1511–1520. doi:10.1016/S0140-6736(17)31665-3
   PubMed Web of Science ®Google Scholar
• Butreddy A, Dudhipala N, Janga KY, Gaddam RP. Lyophilization of small-molecule injectables: an industry perspective on formulation development, process optimization, scale-up challenges, and drug product quality attributes. AAPS PharmSciTech. 2020;21(7):252. doi:10.1208/s12249-020-01787-w
   PubMed Web of Science ®Google Scholar
• Leslie SB, Israeli E, Lighthart B, Crowe JH, Crowe LM. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl Environ Microbiol. 1995;61(10):3592–3597. doi:10.1128/aem.61.10.3592-3597.1995
   PubMed Web of Science ®Google Scholar